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Abstract
The relationship between intensity of inﬂammatory stimulation and production of a2-macroglobulin (a2M) and a1-acid
glycoprotein (AAG) in rats was investigated. Sprague-Dawley rats were injected with turpentine oil at doses of 0.05, 0.2 or
0.4 mL/rat. Serum levels of a2M, interleukin (IL)-6 and cytokine-induced neutrophil chemoattractant-1 (CINC-1) were
measured by enzyme-linked immunosorbent assay, and AAG was measured by single radial immunodiffusion. Peak serum
levels of a2M and AAG in rats injected at 0.05 mL/rat were signiﬁcantly lower than those at 0.2 or 0.4 mL/rat. However, no
signiﬁcant differences were observed for peak serum levels of these acute-phase proteins between 0.2 and 0.4 mL/rat.
Furthermore, peak serum levels of IL-6 and CINC-1 in rats injected at 0.05 mL/rat were signiﬁcantly lower than those at 0.2 or
0.4 mL/rat. Thus, the production of these acute-phase proteins has upper limits, even under increased strength of
inﬂammatory stimulation in rats injected with turpentine oil.
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Acute-phase protein levels increase during acute inﬂam-
mation, e.g. bacterial infection, trauma and surgical treat-
ment.
1–3 C-reactive protein is a typical acute-phase protein
in humans and dogs,
4–7 while a2-macroglobulin (a2M) is
a typical acute-phase protein in rats.
8–10a2M levels increase
in rats subjected to acute inﬂammation by inoculation with
microorganisms, injection of turpentine oil or after surgical
treatment.
9 a1-acid glycoprotein (AAG) contributes to
protein binding with anionic drug substances, and also
increases following inﬂammatory stimulation.
11,12
Peak levels of a2M differ after injection of turpentine oil,
inoculation with microorganisms or surgical treatment.
8,9
Furthermore, peak levels of AAG also differ after injection
of turpentine oil, inoculation with microorganisms and
gastric bleeding by injection of indomethacin.
12 Peak
levels of these acute-phase proteins are thus presumed to
differ with the magnitude of inﬂammatory stimulation in
rats. a2M and AAG are considered to be typical inﬂamma-
tory markers in rats. However, there has been little basic
research on these proteins, and little is known about the
differences in production based on the magnitude of stimu-
lation. Thus, degree of inﬂammation cannot be estimated
based on production of a2M or AAG.
In the present study, the changes in serum levels of a2M
and AAG in rats subjected to various dosages of turpentine
oil to induce acute inﬂammation were investigated in an
effort to clarify whether the production of acute-phase pro-
teins varies with the magnitude of inﬂammatory stimulation.
Materials and methods
Animals
Eighteen nine-week-old Sprague-Dawley rats were pur-
chased from Charles River, Inc (Yokohama, Japan), and
were used in the present study. Rats were kept in isolators
at a temperature of 23+28C, and a relative humidity of
55+10%, on a 12/12 h dark/light cycle (06:00–18:00)
with air exchanged 12 times or more per hour. Rats were
fed MF (Oriental Yeast Co, Ltd, Tokyo, Japan), and were
allowed free access to water.
All experiments were approved by the Institutional
Review Board of Azabu University and conducted in
accordance with the Institute’s Animal Experimentation
Guidelines (Japanese Association for Laboratory Animal
Science, JALAS, 1987).
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Rats were divided into three groups (n ¼ 6 for each group).
Turpentine oil (Wako Pure Chemical Industries, Ltd,
Osaka, Japan) was injected intramuscularly into rats at
0.05, 0.2 or 0.4 mL/rat. Acute-phase protein levels are
known to increase after intramuscular injection of turpen-
tine oil,
8,9,13–15 which has been used to induce acute inﬂam-
mation in several studies, primarily because turpentine oil is
able to induce constant acute inﬂammation, as compared
with infection by microorganisms or other chemical com-
pounds.
8,9 Turpentine oil was thus used to induce acute
inﬂammation in this study. Blood (0.3 mL) was collected
before injection and at 6, 12, 24, 48, 72 and 96 h after
administration. Blood was collected from the venae cervica-
lis superﬁcialis using a syringe under mild anaesthesia with
pentobarbital (Kyoritsu Seiyaku Corporation, Tokyo,
Japan). Pentobarbital was intravenously administered at
small doses (4 mg/kg) in order to ensure only short-term
effects. Sera were obtained by centrifugation at 1600 g for
15 min, and were stored at 2808C until analysis.
Measurement of a2M and AAG
Serum levels of a2M were measured by enzyme-linked
immunosorbent assay (ELISA) according to the procedure
of Honjo et al.
16 Serum levels of AAG were measured by
single radial immunodiffusion using a commercial kit
(Institute for Metabolic Ecosystem Co, Ltd, Miyagi, Japan).
Measurement of interleukin-6 and cytokine-induced
neutrophil chemoattractant-1
Serum levels of interleukin-6 (IL-6) and cytokine-induced
neutrophil chemoattractant (CINC-1) were measured by
ELISA using commercial kits. Commercial ELISA kits
were purchased from BioSource International, Inc
(Camarillo, CA, USA) for IL-6 and from Panapharm
Laboratories Co, Ltd (Kumamoto, Japan) for CINC-1.
Statistics
All values are expressed as means+SD (n ¼ 6). Analysis of
signiﬁcance between variables was performed using
unpaired Student’s t-test. P values of ,0.05 were considered
to be statistically signiﬁcant.
Results
Changes in serum levels of a2M, AAG, IL-6 and CINC-1 are
shown in Figure 1. Peak levels of a2M were observed at 48 h
after injection of 0.05, 0.2 or 0.4 mL/rat. Peak a2M levels
were 1071.2+324.4 mg/mL in the 0.05 mL/rat injection
group, 1667.4+478.7 mg/mL in the 0.2 mL/rat injection
group and 1808.0+563.5 mg/mL in the 0.4 mL/rat injection
group. Peak levels in the 0.05 mL/rat injection group were
signiﬁcantly lower than those in the 0.2 and 0.4 mL/rat
injection groups. However, no signiﬁcant differences were
observed between the 0.2 and 0.4 mL/rat injection groups.
Serum levels of AAG also peaked at 48 h after injection in
all groups. Peaks for AAG were 1554.8+302.8 mg/mL in
the 0.05 mL/rat injection group, 2667.6+451.1 mg/mL
in the 0.2 mL/rat injection group and 2962.8+285.0 mg/mL
in the 0.4 mL/rat injection group. Peak levels of AAG in the
0.05 mL/rat injection group were signiﬁcantly lower than
those in the 0.2 and 0.4 mL/rat injection groups.
Peak serum levels of IL-6 and CINC-1 were observed
at 12 h after injection in all injection groups. Peak levels
of IL-6 were 120.5+36.0 pg/mL in the 0.05 mL/rat injec-
tion group, 361.0+192.9 pg/mL in the 0.2 mL/rat injection
group and 508.6+76.2 pg/mL in the 0.4 mL/rat injection
group. Peak levels in the 0.05 mL/rat injection group were
signiﬁcantly lower than in the 0.2 and 0.4 mL/rat injection
groups. No signiﬁcant differences were observed between
the 0.2 and the 0.4 mL/rat injection groups, except at 24 h
after injection.
Peaks for CINC-1 were 2812.3+755.8 pg/mL in the
0.05 mL/rat injection group, 6734.8+2898.2 pg/mL in the
0.2 mL/rat injection group and 7449.8+2698.5 pg/mL in
the 0.4 mL/rat injection group. Peaks levels in the 0.05
mL/rat injection group were signiﬁcantly lower than those
in the 0.2 and 0.4 mL/rat injection groups. No signiﬁcant
differences were observed between the 0.2 and 0.4 mL/rat
injection groups.
Discussion
Serum levels of the typical acute-phase proteins a2M and
AAG in rats after inﬂammatory stimulation with various
doses of turpentine oil were examined in an effort to
clarify the differences in production during various
degrees of inﬂammatory stimulation. Serum levels of a2M
and AAG in rats injected with 0.05 mL/rat were signiﬁ-
cantly lower than those injected with 0.2 and 0.4 mL/rat;
however, no signiﬁcant differences were observed between
the 0.2 and 0.4 mL/rat injection groups. These results
suggest that production of a2M and AAG increases in pro-
portion with turpentine oil dose. Production of a2M and
AAG was similar above 0.2 mL/rat; however, limited pro-
duction was observed. Thus, it was necessary to carefully
evaluate the degree of inﬂammation based on the levels of
these acute-phase proteins.
IL-6 is known to regulate the synthesis of acute-phase
proteins,
17–22 while IL-8 regulates the production of acute-
phase proteins in humans.
23,24 However, IL-8 has not been
observed in rats, and CINC-1 is considered to be the
counterpart of human IL-8.
25–28 On the other hand, serum
levels of seven cytokines (IL-1, IL-2, IL-4, IL-6, CINC-1,
IL-10 and interferon-g) in rats injected with turpentine oil
have been investigated, and only serum levels of IL-6 and
CINC-1 were elevated prior to increases in a2M.
9 In con-
trast, levels of the cytokines IL-1, IL-2, IL-4, IL-10 and
interferon-g did not change.
9 IL-6 and CINC-1 also
increased prior to AAG in rats injected with turpentine
oil.
12 Furthermore, the changes in serum levels of a2M
and AAG after repeated injection of turpentine oil at
doses of 0.05 and 0.4 mL/rat showed a similar pattern as
with single stimulation, and peak serum levels in rats
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This phenomenon was thought to be caused by differences
in the production of IL-6 and CINC-1 in the two groups.
29
Thus, IL-6 and CINC-1 apparently contribute to the pro-
duction of a2M and AAG in rats.
16 In the present study,
levels of IL-6 and CINC-1 in rats injected with 0.05 mL
were also signiﬁcantly lower than those injected with 0.2
and 0.4 mL/rat. The levels of both cytokines did not differ sig-
niﬁcantly between the 0.2 and the 0.4 mL/rat injection
groups. The four parameters evaluated in the present study
showed similar patterns. The signiﬁcant differences in pro-
duction of a2M and AAG independent of the turpentine oil
dosage are considered to be attributable to signiﬁcant differ-
ences in the production of IL-6 and CINC-1. These results
thus suggest that IL-6 and CINC-1 regulate the production
of a2M and AAG.
In summary, the production of a2M and AAG has an
upper limit, irrespective of the magnitude of stimulation.
Production of a2M and AAG showed similar trends to
those of IL-6 and CINC-1; thus, the kinetics of these cyto-
kines inﬂuenced the production of a2M and AAG.
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